NAV
$53.82
AUM
$131.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.04
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +22.06% | +17.42% | +29.72% | +36.81% | +6.90% | -3.51% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | MOH | Molina Healthcare Inc | 4.77% |
| 2 | BTSG | BrightSpring Health Services Inc | 4.35% |
| 3 | KRYS | Krystal Biotech Inc | 4.25% |
| 4 | ALKS | Alkermes PLC | 3.72% |
| 5 | CORT | Corcept Therapeutics Inc | 3.47% |
| 6 | GKOS | Glaukos Corp | 3.17% |
| 7 | PTCT | PTC Therapeutics Inc | 3.16% |
| 8 | PTGX | Protagonist Therapeutics Inc | 3.12% |
| 9 | TFX | Teleflex Inc | 3.03% |
| 10 | TGTX | TG Therapeutics Inc | 2.75% |
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
Inception Date: 2010-04-07